M42, the global health powerhouse, has signed a groundbreaking agreement with AstraZeneca, a global leader in science-led biopharmaceuticals, to advance preventive healthcare and next-generation precision medicine.
As AstraZeneca’s clinical genomics partner of choice in the Middle East region, M42 will conduct sequencing of
Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and Coexistence, opened the inaugural Cleveland Clinic Global Summit on Innovations in Cancer Care that took place at the Four Seasons Hotel in Abu Dhabi.
The three-day summit, hosted by Cleveland Clinic Abu Dhabi, part of the M42 group, brought together over 30 leading oncology
The Smart Hospital and Interoperability Zone at Arab Health 2024 began this morning with a high-level panel discussion on environmental sustainability in Middle Eastern healthcare. This pivotal session brought together industry leaders and experts to explore strategies for integrating sustainability into the region's healthcare
With business intelligence firm Grand View Research anticipating that the global longevity and anti-ageing market will reach $183 billion by 2028, the scientific and medical community is now focusing on a new paradigm in human health and a new market in life sciences with almost limitless potential.
Field pioneers and world-leading
NYU Abu Dhabi (NYUAD), in collaboration with Tamkeen, celebrated the completion of the UAE Healthy Future Study’s (UAEHFS) first phase of recruiting nearly 15,000 participants in the UAE’s first-ever prospective cohort study of its kind that seeks to determine how the health of UAE nationals are affected by their lifestyle,
